Free shipping on all orders over $ 500

APR-246 (Eprenetapopt)

Cat. No. M9623

All AbMole products are for research use only, cannot be used for human consumption.

APR-246 (Eprenetapopt) Structure
Synonym:

PRIMA-1MET; Eprenetapopt

Size Price Availability Quantity
1mg USD 30  USD30 In stock
5mg USD 66  USD66 In stock
10mg USD 108  USD108 In stock
25mg USD 216  USD216 In stock
50mg USD 378  USD378 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

APR-246 (Eprenetapopt) is the first-in-class small molecule to restore wild-type p53 function in TP53 mutant cells.

APR-246 (Eprenetapopt), also known as PRIMA-1MET, is a quinuclidinone derivative that targets the Wrap53 gene with potential antineoplastic activity. APR-246 (PRIMA-1MET) enhances apoptosis in mutant p53 carrying cells, compared to the p53 null parental cells. Most p53 mutants are in complex with Hsp70 proteins. APR-246 treatment increases Hsp70 expression and nucleolar translocation, in parallel with the induction of nucleolar accumulation of mutant p53. Several lines of evidence suggest that APR-246 can also act independently of the p53 status of the cell. APR-246 (Eprenetapopt) is the first small molecule to restore wild-type p53 function in TP53 mutant cells. APR-246 also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of REDOX balance in cells.

In animal studies, APR-246 (Eprenetapopt) is well tolerated, APR-246 single treatment inhibits tumor growth by 21% in mice bearing the aggressively growing A2780-CP20 tumor xenografts.

Chemical Information
Molecular Weight 199.25
Formula C10H17NO3
CAS Number 5291-32-7
Solubility (25°C) DMSO ≥ 60 mg/mL
Water ≥ 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] N Mohell, et al. Cell Death Dis. APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells

[2] X Peng, et al. Cell Death Dis. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase

[3] Roza Zandi, et al. Clin Cancer Res. PRIMA-1Met/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53

[4] Gyorgy Stuber, et al. Mol Cancer. PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein

Related p53 Products
Pifithrin-α, p-Nitro, Cyclic

Pifithrin-α, p-Nitro, Cyclic (PFN-α) is cell-permeable and active-form p53 inhibitor. Pifithrin-α, p-Nitro, Cyclic behaves as a p53 posttranscriptional activity inhibitor. Pifithrin-α, p-Nitro, Cyclic do not prevent p53 phosphorylation on the S15 residue.

PK095 

PK095 is a p53 mutant stabilizer.

HLI373 

HLI373 is an efficacious Hdm2 inhibitor.

Cjoc42 

Cjoc42 is a compound capable of binding to gankyrin.

MDM2-IN-1 

MDM2-IN-1 is a synthetic MDM2-p53 interaction (MDM2) inhibitor and contains the trans (D-)configuration.

  Catalog
Abmole Inhibitor Catalog




Keywords: APR-246 (Eprenetapopt), PRIMA-1MET; Eprenetapopt supplier, p53, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.